Shufro Rose & Co’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-47,000
| Closed | -$783K | – | 299 |
|
|
2017
Q3 | $783K | Buy |
47,000
+500
| +1% | +$8.13K | 0.08% | 138 |
|
|
2017
Q2 | $832K | Buy |
46,500
+400
| +0.9% | +$7.47K | 0.09% | 122 |
|
|
2017
Q1 | $924K | Buy |
46,100
+3,000
| +7% | +$69.9K | 0.1% | 122 |
|
|
2016
Q4 | $1.08M | Sell |
43,100
-300
| -0.7% | -$7.09K | 0.12% | 111 |
|
|
2016
Q3 | $1.01M | Sell |
43,400
-3,500
| -7% | -$82.2K | 0.11% | 110 |
|
|
2016
Q2 | $938K | Sell |
46,900
-2,100
| -4% | -$39.2K | 0.1% | 115 |
|
|
2016
Q1 | $830K | Sell |
49,000
-29,900
| -38% | -$613K | 0.09% | 128 |
|
|
2015
Q4 | $1.75M | Sell |
78,900
-2,100
| -3% | -$43.7K | 0.2% | 89 |
|
|
2015
Q3 | $1.37M | Sell |
81,000
-22,300
| -22% | -$347K | 0.17% | 96 |
|
|
2015
Q2 | $1.42M | Buy |
103,300
+500
| +0.5% | +$6.64K | 0.15% | 96 |
|
|
2015
Q1 | $1.41M | Hold |
102,800
| – | – | 0.14% | 100 |
|
|
2014
Q4 | $1.09M | Sell |
102,800
-100
| -0.1% | -$1.18K | 0.11% | 113 |
|
|
2014
Q3 | $1.29M | Sell |
102,900
-7,300
| -7% | -$102K | 0.13% | 106 |
|
|
2014
Q2 | $1.51M | Sell |
110,200
-29,700
| -21% | -$388K | 0.15% | 92 |
|
|
2014
Q1 | $1.69M | Sell |
139,900
-76,900
| -35% | -$881K | 0.18% | 87 |
|
|
2013
Q4 | $2.66M | Sell |
216,800
-52,000
| -19% | -$610K | 0.28% | 74 |
|
|
2013
Q3 | $2.73M | Buy |
268,800
+1,000
| +0.4% | +$9.35K | 0.31% | 71 |
|
|
2013
Q2 | $2.4M | Buy |
+267,800
| New | +$2.7M | 0.29% | 72 |
|
Shufro Rose & Co's OME Position: Q4 2017 in Review
Shufro Rose & Co sold out of Omega Protein (OME) in Q4 2017, closing a stake of 47,000 shares — an estimated $783K sold.
Shufro Rose & Co first reported a position in OME in Q2 2013 and held it in 18 quarters. The position peaked at $2.73M in Q3 2013. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Shufro Rose & Co reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Shufro Rose & Co sold 47,000 Omega Protein shares in Q4 2017, an estimated $783K.
- Shufro Rose & Co first reported a position in Omega Protein in Q2 2013 and held it in 18 quarters.
- Shufro Rose & Co's Omega Protein position peaked at $2.73M in Q3 2013.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Shufro Rose & Co's 13F filing for Q4 2017, filed 6 Feb 2018.